Attitudes toward Medication for Opioid Use Disorder among Substance Use Treatment Providers

References

• Abraham, A. J., Andrews, C. M., Harris, S. J., & Friedmann, P. D. (2020). Availability of medications for the treatment of alcohol and opioid use disorder in the USA. Neurotherapeutics, 17(1), 55–69. 10.1007/s13311-019-00814-4
   PubMed Web of Science ®Google Scholar
• Aletraris, L., Edmond, M. B., Paino, M., Fields, D., & Roman, P. M. (2016). Counselor training and attitudes toward pharmacotherapies for opioid use disorder. Substance Abuse, 37(1), 47–53. https://doi.org/10.1080/08897077.2015.1062457
   PubMed Web of Science ®Google Scholar
• Amram, O., Amiri, S., Panwala, V., Lutz, R., Joudrey, P. J., & Socias, E. (2021). The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era. The American Journal of Drug and Alcohol Abuse, 47(6), 722–729. https://doi.org/10.1080/00952990.2021.1979991
   PubMed Web of Science ®Google Scholar
• Andraka-Christou, B., Gabriel, M., Madeira, J., & Silverman, R. D. (2019). Court personnel attitudes towards medication-assisted treatment: A state-wide survey. Journal of Substance Abuse Treatment, 104, 72–82. https://doi.org/10.1016/j.jsat.2019.06.011
   PubMed Web of Science ®Google Scholar
• Andraka-Christou, B., Nguyen, T., Bradford, D. W., & Simon, K. (2020a). Assessing the impact of drug courts on provider-directed marketing efforts by manufactures of medications for the treatment of opioid use disorder. Journal of Substance Abuse Treatment, 110, 49–58. https://doi.org/10.1016/j.jsat.2019.12.004
   PubMed Web of Science ®Google Scholar
• Andraka-Christou, B., Nguyen, T., Harris, S., Madeira, J., Totaram, R., Randall-Kosich, O., Atkins, D., & Ford, J. (2020b). College students’ perceived knowledge of and perceived helpfulness of treatments for opioid use disorder at two American universities. The American Journal of Drug and Alcohol Abuse, 46(5), 589–603. https://doi.org/10.1080/00952990.2020.1757686
   PubMed Web of Science ®Google Scholar
• Andrews, S., Sorensen, J. L., Guydish, J., Delucchi, K., & Greenberg, B. (2005). Knowledge and attitudes about methadone maintenance among staff working in a therapeutic community. Journal of Maintenance in the Addictions, 3(1), 47–59. https://doi.org/10.1300/J126v03n01_05
   PubMedGoogle Scholar
• Atkinson, H. G., Curnin, K. J., & Hanson, N. C. (2016). U.S. state laws addressing human trafficking: Education of and mandatory reporting by health care providers and other professionals. Journal of Human Trafficking, 2(2), 111–138. https://doi.org/10.1080/23322705.2016.1175885
   Google Scholar
• Beachler, T., Zeller, T. A., Heo, M., Lanzillotta-Rangeley, J., & Litwin, A. H. (2021). Community attitudes toward opioid use disorder and medication for opioid use disorder in a rural Appalachian county. The Journal of Rural Health, 37(1), 29–34. https://doi.org/10.1111/jrh.12503
   PubMed Web of Science ®Google Scholar
• Bergman, B. G., Ashford, R. D., & Kelly, J. F. (2020). Attitudes toward opioid use disorder medications: Results from a U.S. national study of individuals who resolved a substance use problem. Experimental and Clinical Psychopharmacology, 28(4), 449–461. https://doi.org/10.1037/pha0000325
   PubMed Web of Science ®Google Scholar
• Bouchery, E., & Dey, J. (2018). Substance use disorder workforce issue brief. U.S. Department of Health and Human Services. https://aspe.hhs.gov/reports/substance-use-disorder-workforce-issue-brief-0
   Google Scholar
• Bride, B. E., Abraham, A. J., Kintzle, S., & Roman, P. M. (2013). Social workers’ knowledge and perceptions of effectiveness and acceptability of medication assisted treatment of substance use disorders. Social Work in Health Care, 52(1), 43–58. https://doi.org/10.1080/00981389.2012.725457
   PubMed Web of Science ®Google Scholar
• Brown, A. R. (2022). Health professionals’ attitudes toward medications for opioid use disorder. Substance Abuse, 43(1), 598–614. https://doi.org/10.1080/08897077.2021.1975872
   PubMed Web of Science ®Google Scholar
• Brown, B. S., Bass, U. F., Gauvey, S. K., & Kozel, N. J. (1972). Staff and client attitudes toward methadone maintenance. The International Journal of the Addictions, 7(2), 247–255. https://doi.org/10.3109/10826087209026777
   PubMed Web of Science ®Google Scholar
• Brown, B. S., Jansen, D. R., & Bass, U. F. (1974). Staff attitudes and conflict regarding the use of methadone in the treatment of heroin addiction. The American Journal of Psychiatry, 131(2), 215–219. https://doi.org/10.1176/ajp.131.2.215
   PubMed Web of Science ®Google Scholar
• Brown, B. S., Jansen, D. R., & Benn, G. J. (1975). Changes in attitude toward methadone. Archives of General Psychiatry, 32(2), 214–218. https://doi.org/10.1001/archpsyc.1975.01760200078007
   PubMed Web of Science ®Google Scholar
• Caplehorn, J. R. M., Hartel, D. M., & Irwig, L. (1997). Measuring and comparing the attitudes and beliefs of staff working in New York methadone maintenance clinics. Substance Use & Misuse, 32(4), 399–413. https://doi.org/10.3109/10826089709039361
   PubMed Web of Science ®Google Scholar
• Caplehorn, J. R. M., Irwig, L., Saunders, J. B., & Chir, B. (1996). Attitudes and beliefs of staff working in methadone maintenance clinics. Substance Use & Misuse, 31(4), 437–452. https://doi.org/10.3109/10826089609045820
   PubMed Web of Science ®Google Scholar
• Caplehorn, J. R. M., Lumley, T. S., & Irwig, L. (1998). Staff attitudes and retention of patients in methadone maintenance programs. Drug and Alcohol Dependence, 52(1), 57–61. https://doi.org/10.1016/S0376-8716(98)00047-7
   PubMed Web of Science ®Google Scholar
• Chenworth, M., Perrone, J., Love, J. S., Graves, R., Hogg-Bremer, W., & Sarker, A. (2021). Methadone and suboxone mentions on twitter: Thematic and sentiment analysis. Clinical Toxicology, 59(11), 982–991.
   Web of Science ®Google Scholar
• Cioe, K., Biondi, B. E., Easly, R., Simard, A., Zheng, X., & Springer, S. A. (2020). A systematic review of patients’ and providers’ perspectives of medications for treatment of opioid use disorder. Journal of Substance Abuse Treatment, 119, 108146. https://doi.org/10.1016/j.jsat.2020.108146
   PubMed Web of Science ®Google Scholar
• Davenport, E. S., Arnett, S. J., Nichols, M. A., & Miller, M. L. (2020). Indiana community pharmacist preceptors’ knowledge and perceptions of medication-assisted treatment. Journal of the American Pharmacists Association: JAPhA, 60(3S), S20–S28.e4. https://doi.org/10.1016/j.japh.2020.01.001
   PubMedGoogle Scholar
• Davis, C. S., & Samuels, E. A. (2020). Opioid policy changes during the COVID-19 pandemic—And beyond. Journal of Addiction Medicine, 14(4), e4–e5. https://doi.org/10.1097/ADM.0000000000000679
   PubMed Web of Science ®Google Scholar
• Earnshaw, V., Smith, L., & Copenhaver, M. (2013). Drug addiction stigma in the context of methadone maintenance therapy: An investigation into understudied sources of stigma. International Journal of Mental Health and Addiction, 11(1), 110–122. https://doi.org/10.1007/s11469-012-9402-5
   PubMed Web of Science ®Google Scholar
• Figgatt, M. C., Salazar, Z., Day, E., Vincent, L., & Dasgupta, N. (2021). Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19. Journal of Substance Abuse Treatment, 123, 108276. https://doi.org/10.1016/j.jsat.2021.108276
   PubMed Web of Science ®Google Scholar
• Forman, R. F., Bovasso, G., & Woody, G. (2001). Staff beliefs about addiction treatment. Journal of Substance Abuse Treatment, 21(1), 1–9. https://doi.org/10.1016/S0740-5472(01)00173-8
   PubMed Web of Science ®Google Scholar
• Friedmann, P. D., Wilson, D., Knudsen, H. K., Ducharme, L. J., Welsh, W. N., Frisman, L., Knight, K., Lin, H.-J., James, A., Albizu-Garcia, C. E., Pankow, J., Hall, E. A., Urbine, T. F., Abdel-Salam, S., Duvall, J. L., & Vocci, F. J. (2015). Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community corrections. Journal of Substance Abuse Treatment, 50, 50–58. https://doi.org/10.1016/j.jsat.2014.10.001
   PubMed Web of Science ®Google Scholar
• Hayoung, L., Geynisman-Tan, J., Hofer, S., Anderson, E., Caravan, S., & Titchen, K. (2021). The impact of human trafficking training on healthcare professionals’ knowledge and attitudes. Journal of Medical Education and Curricular Development, 8, 23821205211016523. https://doi.org/10.1177/23821205211016523
   Google Scholar
• Health Resources and Services Administration. (2017). Behavioral health workforce projections, 2017–2030. https://bhw.hrsa.gov/sites/default/files/bureau-health-workforce/data-research/bh-workforce-projections-fact-sheet.pdf
   Google Scholar
• Herbeck, D. M., Hser, Y.-I., & Teruya, C. (2008). Empirically supported substance abuse treatment approaches: A survey of treatment providers’ perspectives and practices. Addictive Behaviors, 33(5), 699–712. https://doi.org/10.1016/j.addbeh.2007.12.003
   PubMed Web of Science ®Google Scholar
• Hoffman, L. A., Vilsaint, C. L., & Kelly, J. F. (2021). Attitudes toward opioid use disorder pharmacotherapy among recovery community center attendees. Journal of Substance Abuse Treatment, 131, 108464. https://doi.org/10.1016/j.jsat.2021.108464
   PubMed Web of Science ®Google Scholar
• Jarvis, B. P., Holtyn, A. F., Subramaniam, S., Tompkins, D. A., Oga, E. A., Bigelow, G. E., & Silverman, K. (2018). Extended-release injectable naltrexone for opioid use disorder: A systematic review. Addiction (Abingdon, England), 113(7), 1188–1209. https://doi.org/10.1111/add.14180
   PubMed Web of Science ®Google Scholar
• Johnson, K., Jones, C., Compton, W., Baldwin, G., Fan, J., Mermin, J., & Bennett, J. (2018). Federal response to the opioid crisis. Current HIV/AIDS Reports, 15(4), 293–301. https://doi.org/10.1007/s11904-018-0398-8
   PubMed Web of Science ®Google Scholar
• Joseph, G., Torres-Lockhart, K., Stein, M. R., Mund, P. A., & Nahvi, S. (2021). Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19. Journal of Substance Abuse Treatment, 122, 108219. https://doi.org/10.1016/j.jsat.2020.108219
   PubMed Web of Science ®Google Scholar
• Kampman, K., & Jarvis, M. (2015). American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use. Journal of Addiction Medicine, 9(5), 358–367. https://doi.org/10.1097/ADM.0000000000000166
   PubMed Web of Science ®Google Scholar
• Kennedy-Hendricks, A., Barry, C. L., Stone, E., Bachhuber, M. A., & McGinty, E. E. (2020). Comparing perspectives on medication treatment for opioid use disorder between national samples of primary care trainee physicians and attending physicians. Drug and Alcohol Dependence, 216, 108217. https://doi.org/10.1016/j.drugalcdep.2020.108217
   PubMed Web of Science ®Google Scholar
• Knudsen, H. K., Ducharme, L. J., & Roman, P. M. (2007). Research network involvement and addiction treatment center staff: Counselor attitudes toward buprenorphine. The American Journal on Addictions, 16(5), 365–371. https://doi.org/10.1080/10550490701525418
   PubMed Web of Science ®Google Scholar
• Knudsen, H. K., Ducharme, L. J., Roman, P. M., & Link, T. (2005). Buprenorphine diffusion: The attitudes of substance abuse treatment counselors. Journal of Substance Abuse Treatment, 29(2), 95–106. https://doi.org/10.1016/j.jsat.2005.05.002
   PubMed Web of Science ®Google Scholar
• Lee, J. D., Malone, M., McDonald, R., Cheng, A., Vasudevan, K., Tofighi, B., Garment, A., Porter, B., Goldfeld, K. S., Matteo, M., Mangat, J., Katyal, M., Giftos, J., & MacDonald, R. (2021). Comparison of treatment retention of adults with opioid addiction managed with extended-release buprenorphine vs daily sublingual buprenorphine-naloxone at time of release from jail. JAMA Network Open, 4(9), e2123032. https://doi.org/10.1001/jamanetworkopen.2021.23032
   PubMed Web of Science ®Google Scholar
• Lett, E., Asabor, E., Beltrán, S., Cannon, A. M., & Arah, O. A. (2022). Conceptualizing, contextualizing, and operationalizing race in quantitative health sciences research. Annals of Family Medicine, 20(2), 157–163. https://doi.org/10.1370/afm.2792
   PubMed Web of Science ®Google Scholar
• Lister, J. J., Weaver, A., Ellis, J. D., Himle, J. A., & Ledgerwood, D. M. (2020). A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States. The American Journal of Drug and Alcohol Abuse, 46(3), 273–288. https://doi.org/10.1080/00952990.2019.1694536
   PubMed Web of Science ®Google Scholar
• MacArthur, G. J., Minozzi, S., Martin, N., Vickerman, P., Deren, S., Bruneau, J., Degenhardt, L., & Hickman, M. (2012). Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis. BMJ, 345(oct03 3), e5945. https://doi.org/10.1136/bmj.e5945
   PubMedGoogle Scholar
• Madden, E. F. (2019). Intervention stigma: How medication-assisted treatment marginalizes patients and providers. Social Science & Medicine (1982), 232, 324–331. https://doi.org/10.1016/j.socscimed.2019.05.027
   PubMed Web of Science ®Google Scholar
• Majer, J. M., Beasley, C., Stecker, E., Bobak, T. J., Norris, J., Nguyen, H. M., Ogata, M., Siegel, J., Wiedbusch, E., Dovale, I., Gelfman, N., Callahan, S., & Jason, L. A. (2018). Oxford house residents’ attitudes toward medication assisted treatment use in fellow residents. Community Mental Health Journal, 54(5), 571–577. https://doi.org/10.1007/s10597-017-0218-4
   PubMed Web of Science ®Google Scholar
• Malvini Redden, S., Tracy, S. J., & Shafer, M. S. (2013). A metaphor analysis of recovering substance abusers’ sensemaking of medication-assisted treatment. Qualitative Health Research, 23(7), 951–962. https://doi.org/10.1177/1049732313487802
   PubMed Web of Science ®Google Scholar
• Pescosolido, B. A., & Martin, J. K. (2015). The stigma complex. Annual Review of Sociology, 41(1), 87–116. https://doi.org/10.1146/annurev-soc-071312-145702
   PubMed Web of Science ®Google Scholar
• Pytell, J. D., & Rastegar, D. A. (2021). Down the drain: Reconsidering routine urine drug testing during the COVID-19 pandemic. Journal of Substance Abuse Treatment, 120, 108155. https://doi.org/10.1016/j.jsat.2020.108155
   PubMed Web of Science ®Google Scholar
• Richard, E. L., Schalkoff, C. A., Piscalko, H. M., Brook, D. L., Sibley, A. L., Lancaster, K. E., Miller, W. C., & Go, V. F. (2020). “You are not clean until you’re not on anything”: Perceptions of medication-assisted treatment in rural Appalachia. The International Journal on Drug Policy, 85, 102704. https://doi.org/10.1016/j.drugpo.2020.102704
   PubMed Web of Science ®Google Scholar
• Rieckmann, T. R., Kovas, A. E., McFarland, B. H., & Abraham, A. J. (2011). A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment. Journal of Substance Abuse Treatment, 41(4), 374–385. https://doi.org/10.1016/j.jsat.2011.05.005
   PubMed Web of Science ®Google Scholar
• Schuckit, M. A. (2016). Treatment of opioid-use disorders. The New England Journal of Medicine, 375(4), 357–368. https://doi.org/10.1056/NEJMra1604339
   PubMed Web of Science ®Google Scholar
• Schwartz, R. P., Kelly, S. M., O'Grady, K. E., Mitchell, S. G., Peterson, J. A., Reisinger, H. S., Agar, M. H., & Brown, B. S. (2008). Attitudes toward buprenorphine and methadone among opioid-dependent individuals. American Journal on Addictions, 17(5), 396–401. https://doi.org/10.1080/10550490802268835
   PubMed Web of Science ®Google Scholar
• Scott, K., Murphy, C. M., Yap, K., Moul, S., Hurley, L., & Becker, S. J. (2021). Health professional stigma as a barrier to contingency management implementation in opioid treatment programs. Translational Issues in Psychological Science, 7(2), 166–176. https://doi.org/10.1037/tps0000245
   PubMedGoogle Scholar
• Stone, E. M., Kennedy-Hendricks, A., Barry, C. L., Bachhuber, M. A., & McGinty, E. E. (2021). The role of stigma in U.S. primary care physicians’ treatment of opioid use disorder. Drug and Alcohol Dependence, 221, 108627. https://doi.org/10.1016/j.drugalcdep.2021.108627
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. (2022a). Addiction Technology Transfer Center (ATTC) network. https://attcnetwork.org/
   Google Scholar
• Substance Abuse and Mental Health Services Administration. (2022b). Providers clinical support system. https://pcssnow.org/
   Google Scholar
• Sulzer, S. H., Prevedel, S., Barrett, T., Voss, M. W., Manning, C., & Madden, E. F. (2021). Professional education to reduce provider stigma toward harm reduction and pharmacotherapy. Drugs: Education, Prevention and Policy, 1–11. https://doi.org/10.1080/09687637.2021.1936457
   Google Scholar
• Thakrar, A. P., Alexander, G. C., & Saloner, B. (2021). Trends in buprenorphine use in US jails and prisons from 2016 to 2021. JAMA Network Open, 4(12), e2138807. https://doi.org/10.1001/jamanetworkopen.2021.38807
   PubMed Web of Science ®Google Scholar
• The American College of Obstetricians and Gynecologists. (2017). Opioid use and opioid use disorder in pregnancy (No. 711; ACOG Committee Opinion). https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/08/opioid-use-and-opioid-use-disorder-in-pregnancy
   Google Scholar
• Tofighi, B., El Shahawy, O., Segoshi, A., Moreno, K. P., Badiei, B., Sarker, A., & Krawczyk, N. (2021). Assessing perceptions about medications for opioid use disorder and Naloxone on Twitter. Journal of Addictive Diseases, 39(1), 37–45. https://doi.org/10.1080/10550887.2020.1811456
   PubMed Web of Science ®Google Scholar
• Treitler, P. C., Bowden, C. F., Lloyd, J., Enich, M., Nyaku, A. N., & Crystal, S. (2022). Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms. Journal of Substance Abuse Treatment, 132, 108514. https://doi.org/10.1016/j.jsat.2021.108514
   PubMed Web of Science ®Google Scholar
• Uebelacker, L. A., Bailey, G., Herman, D., Anderson, B., & Stein, M. (2016). Patients’ beliefs about medications are associated with stated preference for methadone, buprenorphine, naltrexone, or no medication-assisted therapy following inpatient opioid detoxification. Journal of Substance Abuse Treatment, 66, 48–53. https://doi.org/10.1016/j.jsat.2016.02.009
   PubMed Web of Science ®Google Scholar
• University of Michigan Department of Anesthesiology. (2022). The Michigan Opioid Collaborative. Michigan Opioid Collaborative. https://michiganopioidcollaborative.org/
   Google Scholar
• Wakeman, S. E., Larochelle, M. R., Ameli, O., Chaisson, C. E., McPheeters, J. T., Crown, W. H., Azocar, F., & Sanghavi, D. M. (2020). Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Network Open, 3(2), e1920622. https://doi.org/10.1001/jamanetworkopen.2019.20622
   PubMed Web of Science ®Google Scholar
• Witte, T. H., Jaiswal, J., Mumba, M. N., & Mugoya, G. C. T. (2021). Stigma surrounding the use of medically assisted treatment for opioid use disorder. Substance Use & Misuse, 56(10), 1467–1475. https://doi.org/10.1080/10826084.2021.1936051
   PubMed Web of Science ®Google Scholar
• Woo, J., Bhalerao, A., Bawor, M., Bhatt, M., Dennis, B., Mouravska, N., Zielinski, L., & Samaan, Z. (2017). “Don’t judge a book by its cover”: A qualitative study of methadone patients’ experiences of stigma. Substance Abuse: Research and Treatment, 11, 1178221816685087. https://doi.org/10.1177/1178221816685087
   Web of Science ®Google Scholar
• Wood, C. A., Duello, A., Miles, J., Lohmann, B., Gochez-Kerr, T., Richardson, K., Anderson-Harper, R., & Winograd, R. P. (2022). Acceptance of medications for opioid use disorder in recovery housing programs in Missouri. Journal of Substance Abuse Treatment, 138, 108747. https://doi.org/10.1016/j.jsat.2022.108747
   PubMedGoogle Scholar
• Zule, W. A., & Desmond, D. P. (1998). Attitudes toward methadone maintenance: Implications for HIV prevention. Journal of Psychoactive Drugs, 30(1), 89–97. https://doi.org/10.1080/02791072.1998.10399674
   PubMed Web of Science ®Google Scholar